SCHEMBL7122374

SCHEMBL7122374

CCCCCC(CCOCC)c1cc(OC)ccc1C=CC(=O)O

nearest known ligand 0.40

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.40
ALDH1A1 P00352 3/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
POLB P06746 1/20 0.40
PLA2G2D Q9UNK4 1/20 0.39
CYSLTR2 Q9NS75 1/20 0.39
CYSLTR1 Q9Y271 1/20 0.39
APP P05067 3/20 0.38
THRB P10828 1/20 0.38
ATM Q13315 1/20 0.38
KMT2A Q03164 2/20 0.38
PDE5A O76074 1/20 0.38
MEN1 O00255 1/20 0.38
MAPT P10636 1/20 0.38
GAA P10253 2/20 0.37
HDAC8 Q9BY41 3/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20480680 0.91 CYSLTR2 (0.43) KDM4EALDH1A1SMN1; SMN2PLA2G2DCYSLTR2
SCHEMBL126602 0.88 PLA2G2D (0.42) KDM4EALDH1A1SMN1; SMN2PLA2G2DCYSLTR2
SCHEMBL303215 0.88 PLA2G2D (0.42) KDM4EALDH1A1SMN1; SMN2PLA2G2DCYSLTR2
SCHEMBL8523379 0.82 THRB (0.43) KDM4EALDH1A1SMN1; SMN2PLA2G2DCYSLTR2
SCHEMBL8523376 0.82 THRB (0.43) KDM4EALDH1A1SMN1; SMN2PLA2G2DCYSLTR2
SCHEMBL19183552 0.82 THRB (0.40) KDM4EALDH1A1SMN1; SMN2PLA2G2DCYSLTR2
SCHEMBL9556877 0.82 THRB (0.40) KDM4EALDH1A1SMN1; SMN2PLA2G2DCYSLTR2
Coumarinic Acid Methyl Ether SCHEMBL14889493 0.81 GAA (0.50) KDM4EALDH1A1SMN1; SMN2PLA2G2DKMT2A
SCHEMBL7119159 0.80 THRB (0.39) KDM4EALDH1A1SMN1; SMN2PLA2G2DCYSLTR2
SCHEMBL8025820 0.78 PLA2G2D (0.42) KDM4EALDH1A1SMN1; SMN2PLA2G2DCYSLTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0756477-B1 METHODS FOR PHOTOTHERAPEUTIC TREATMENT OF PROLIFERATIVE SKIN DISEASES GEN HOSPITAL CORP (US) 2003-11-19 EP disclosed